Yıl: 2020 Cilt: 25 Sayı: 1 Sayfa Aralığı: 1 - 8 Metin Dili: Türkçe DOI: 10.5578/flora.202001 İndeks Tarihi: 29-10-2020

Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi

Öz:
2019 koronavirüs salgınının başlangıcında 2019-nCoV olarak isimlendirilen yeni koronavirüs, salgının ilerleyen dönemlerinde SARSCoV-2 adını almıştır. Virüsün yol açtığı klinik hastalığa koronavirüs hastalığı 2019 (COVID-19) adı verilmiştir. COVID-19, 11 Mart 2020tarihinde Dünya Sağlık Örgütü tarafından pandemi olarak kabul edilmiştir. 26 Mart 2020 tarihi itibariyle küresel ölçekte 462.684doğrulanmış olgu ve 20.834 ölüm görülmüştür, önümüzdeki günlerde de bu sayıların artacağı öngörülmektedir. Oluşturulan çeşitlimodellerle virüsün yayılım dinamikleri araştırılmakta, inkübasyon süresi ve temel çoğalma sayısı ($R_0$) gibi salgın parametreleri aydınlatılmaya çalışılmaktadır. Paylaşılan resmi verilere göre 26 Mart 2020 itibariyle ülkemizde hasta sayısı 3629, ölüm sayısı ise 75’tir. TürkiyeCumhuriyeti Sağlık Bakanlığı tarafından hazırlanan COVID-19 Rehberi ek korunma ve tedavi stratejileriyle devamlı güncellenmektedir.Pandeminin bundan sonraki seyrine yönelik çeşitli tahminler yapılmakta, virüsün Afrika’daki yayılımının ve mevsimsel değişikliklerin bukonu üzerindeki katkısı araştırılmaktadır
Anahtar Kelime:

2019 Coronavirus Pandemic in Turkey and Across the World

Öz:
The novel coronavirus, which was called 2019-nCoV at the beginning of the outbreak, was named SARS-CoV-2 later. The clinical disease caused by the virus was also called Coronavirus disease 2019 (COVID-19). World Health Organization declared COVID-19 a global pandemic on 11.03.2020. As of 26.03.2020, there have been 462.684 confirmed cases and 20.834 deaths globally, and these numbers are expected to increase in the coming days. The dynamics of virus spread are investigated with various models and outbreak parameters such as incubation time and basic reproduction number ($R_0$) is tried to be illuminated. According to official numbers, as of 03.26.2020, there have also been 3629 cases and 75 deaths in Turkey. COVID-19 Guideline prepared by the Ministry of Health of the Republic of Turkey is constantly updated with additional prevention and treatment strategies. Various predictions are made for the future course of the pandemic, and the contribution of the spread of the virus in Africa and seasonal changes on this issue has been investigated.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. McIntosh K, Becker WB, Chanock RM. Growth in suckling-mouse brain of “IBV-like” viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A 1967;58(6):2268-73.
  • 2. Witte KH, Tajima M, Easterday BC. Morphologic characteristics and nucleic acid type of transmissible gastroenteritis virus of pigs. Arch Gesamte Virusforsch 1968;23(1):53-70.
  • 3. Tyrrell DA, Almeida JD, Cunningham CH, Dowdle WR, Hofstad MS, McIntosh K, et al. Coronaviridae. Intervirology 1975;5(1-2):76-82.
  • 4. Bennett J, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier/Saunders, 2014.
  • 5. T.C. Sağlık Bakanlığı. COVID-19 Sağlık Çalışanları Rehberi. 2020.
  • 6. Perlman S. Another decade, another coronavirus. N Engl J Med 2020.
  • 7. Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003;52(Pt 8):715-20.
  • 8. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2020.
  • 9. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019- nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020.
  • 10. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020.
  • 11. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. 2020. Available from: https://www.sciencemag.org/news/2020/02/
  • paper-non-symptomatic-patient-transmitting-coronavirus-wrong. 12. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020.
  • 13. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020.
  • 14. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020.
  • 15. Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med 2020.
  • 16. Wong G, Liu W, Liu Y, Zhou B, Bi Y, Gao GF. MERS, SARS, and Ebola: The role of super-spreaders in infectious disease. Cell Host Microbe 2015;18(4):398-401.
  • 17. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020.
  • 18. Hoehl S, Berger A, Kortenbusch M, Cinatl J, Bojkova D, Rabenau H, et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N Engl J Med 2020.
  • 19. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020.
  • 20. Novel coronavirus pneumonia emergency response epidemiology. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41(2):145-51.
  • 21. World Health Organization. Novel Coronavirus (2019- nCoV) Situation Report-51. 2020.
  • 22. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-66. 2020.
  • 23. European Centre for Disease Prevention and Control. Situation update for the EU/EEA and the UK, as of 27 March 2020. 2020.
  • 24. Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA 2020.
  • 25. Available from: https://www.worldometers.info/coronavirus/.
  • 26. Coronavirus cases have dropped sharply in South Korea. What’s the secret to its success? 2020. Available from: https://www.sciencemag.org/news/2020/03/coronavirus-cases-have-dropped-sharply-south-korea-whats-secret-its-success.
  • 27. China’s aggressive measures have slowed the coronavirus. They may not work in other countries 2020. Available from: https://www.sciencemag.org/news/2020/03/ china-s-aggressive-measures-have-slowed-coronavirus-they-may-not-work-other-countries.
  • 28. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004;59(3):252-6.
  • 29. Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, et al. Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 2018;19(1):81.
  • 30. Sheahan TP, Sims AC, Leist SR, Schafer A, Won J, Brown AJ, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020;11(1):222.
  • 31. Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020;14(1):72-3.
  • 32. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020.
  • 33. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020;19(3):149-50.
  • 34. Ramaiah A, Arumugaswami V. Insights into cross-species evolution of novel human coronavirus 2019-nCoV and defining immune determinants for vaccine development. bioRxiv 2020:2020.01.29.925867.
  • 35. Genovese MC, Kremer J, Zamani O, Ludivico C, Krogulec M, Xie L, et al. Baricitinib in patients with refractory rheumatoid arthritis. N Engl J Med 2016;374(13):1243-52.
  • 36. Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, et al. Baricitinib as potential treatment for 2019- nCoV acute respiratory disease. The Lancet.
  • 37. Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boelle PY, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet 2020;395(10227):871-7.
  • 38. Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Swiss Med Wkly 2020;150:w20224.
  • 39. Kockerling E, Karrasch L, Schweitzer A, Razum O, Krause G. Public health research resulting from one of the World’s largest outbreaks caused by entero-hemorrhagic Escherichia coli in Germany 2011: a review. Front Public Health 2017;5:332.
  • 40. Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010;28(31):4895-902.
  • 41. Kaner J, Schaack S. Understanding Ebola: the 2014 epidemic. Global Health 2016;12(1):53.
  • 42. Kobres PY, Chretien JP, Johansson MA, Morgan JJ, Whung PY, Mukundan H, et al. A systematic review and evaluation of Zika virus forecasting and prediction research during a public health emergency of international concern. PLoS Negl Trop Dis 2019;13(10):e0007451.
APA Er A, Unal S (2020). Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. , 1 - 8. 10.5578/flora.202001
Chicago Er Ahmet Görkem,Unal Serhat Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. (2020): 1 - 8. 10.5578/flora.202001
MLA Er Ahmet Görkem,Unal Serhat Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. , 2020, ss.1 - 8. 10.5578/flora.202001
AMA Er A,Unal S Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. . 2020; 1 - 8. 10.5578/flora.202001
Vancouver Er A,Unal S Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. . 2020; 1 - 8. 10.5578/flora.202001
IEEE Er A,Unal S "Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi." , ss.1 - 8, 2020. 10.5578/flora.202001
ISNAD Er, Ahmet Görkem - Unal, Serhat. "Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi". (2020), 1-8. https://doi.org/10.5578/flora.202001
APA Er A, Unal S (2020). Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, 25(1), 1 - 8. 10.5578/flora.202001
Chicago Er Ahmet Görkem,Unal Serhat Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 25, no.1 (2020): 1 - 8. 10.5578/flora.202001
MLA Er Ahmet Görkem,Unal Serhat Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, vol.25, no.1, 2020, ss.1 - 8. 10.5578/flora.202001
AMA Er A,Unal S Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi. 2020; 25(1): 1 - 8. 10.5578/flora.202001
Vancouver Er A,Unal S Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi. 2020; 25(1): 1 - 8. 10.5578/flora.202001
IEEE Er A,Unal S "Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi." Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, 25, ss.1 - 8, 2020. 10.5578/flora.202001
ISNAD Er, Ahmet Görkem - Unal, Serhat. "Dünyada ve Türkiye’de 2019 Koronavirüs Pandemisi". Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 25/1 (2020), 1-8. https://doi.org/10.5578/flora.202001